383 related articles for article (PubMed ID: 25446425)
41. Contrast-enhanced ultrasound in the characterization of hepatocellular carcinomas treated by ablation: comparison with contrast-enhanced magnetic resonance imaging.
Qu P; Yu X; Liang P; Cheng Z; Han Z; Liu F; Yu J
Ultrasound Med Biol; 2013 Sep; 39(9):1571-9. PubMed ID: 23830098
[TBL] [Abstract][Full Text] [Related]
42. Combined hepatectomy and microwave ablation for multifocal hepatocellular carcinoma: Long-term outcomes and prognostic factors.
Ryu T; Takami Y; Wada Y; Sasaki S; Imamura H; Ureshino H; Saitsu H
Asian J Surg; 2021 Jan; 44(1):186-191. PubMed ID: 32473893
[TBL] [Abstract][Full Text] [Related]
43. Percutaneous ultrasound-guided radiofrequency ablation (RFA) using saline-perfused (wet) needle electrodes for the treatment of hepatocellular carcinoma--long term experience.
Hänsler J; Frieser M; Tietz V; Uhlke D; Wissniowski TT; Bernatik T; Hahn EG; Strobel D
Ultraschall Med; 2007 Dec; 28(6):604-11. PubMed ID: 18074314
[TBL] [Abstract][Full Text] [Related]
44. Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation.
Xu HX; Xie XY; Lu MD; Chen JW; Yin XY; Xu ZF; Liu GJ
Clin Radiol; 2004 Jan; 59(1):53-61. PubMed ID: 14697375
[TBL] [Abstract][Full Text] [Related]
45. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
46. Microwave ablation of giant hepatic cavernous hemangiomas.
Ziemlewicz TJ; Wells SA; Lubner MA; Musat AI; Hinshaw JL; Cohn AR; Lee FT
Cardiovasc Intervent Radiol; 2014 Oct; 37(5):1299-305. PubMed ID: 25023180
[TBL] [Abstract][Full Text] [Related]
47. Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy.
Kim SW; Rhim H; Park M; Kim H; Kim YS; Choi D; Lim HK
Korean J Radiol; 2009; 10(4):366-76. PubMed ID: 19568465
[TBL] [Abstract][Full Text] [Related]
48. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience.
Rhim H; Lim HK; Kim YS; Choi D
AJR Am J Roentgenol; 2008 Jan; 190(1):91-8. PubMed ID: 18094298
[TBL] [Abstract][Full Text] [Related]
49. Clinical utility of radiofrequency ablation following transarterial injection of miriplatin-iodized oil suspension in small hepatocellular carcinoma.
Nakajima K; Yamanaka T; Nakatsuka A; Haruyuki T; Fujimori M; Sugino Y; Matsushita N; Sakuma H; Isaji S; Takei Y; Yamakado K
Jpn J Radiol; 2016 Sep; 34(9):640-6. PubMed ID: 27455985
[TBL] [Abstract][Full Text] [Related]
50. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
[TBL] [Abstract][Full Text] [Related]
51. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.
Lencioni R; Cioni D; Crocetti L; Franchini C; Pina CD; Lera J; Bartolozzi C
Radiology; 2005 Mar; 234(3):961-7. PubMed ID: 15665226
[TBL] [Abstract][Full Text] [Related]
52. Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
Hoffmann R; Rempp H; Syha R; Ketelsen D; Pereira PL; Claussen CD; Clasen S
Eur J Radiol; 2014 Oct; 83(10):1793-8. PubMed ID: 25052871
[TBL] [Abstract][Full Text] [Related]
53. Radiofrequency ablation combined with chemoembolization: treatment of recurrent hepatocellular carcinomas after hepatectomy.
Takaki H; Yamakado K; Sakurai H; Nakatsuka A; Shiraki K; Isaji S; Takeda K
AJR Am J Roentgenol; 2011 Aug; 197(2):488-94. PubMed ID: 21785099
[TBL] [Abstract][Full Text] [Related]
54. Histopathologic comparison of monopolar versus no-touch multipolar radiofrequency ablation to treat hepatocellular carcinoma within Milan criteria.
Seror O; N'Kontchou G; Van Nhieu JT; Rabahi Y; Nahon P; Laurent A; Trinchet JC; Cherqui D; Vicaut E; Beaugrand M; Sellier N
J Vasc Interv Radiol; 2014 Apr; 25(4):599-607. PubMed ID: 24529547
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of percutaneous radiofrequency ablation of hepatic malignant tumors using a perfused-cooled electrode.
Panpikoon T; Treesit T; Thapaneeyakorn J; Wedsart B; Inman T
J Med Assoc Thai; 2013 Jan; 96(1):77-82. PubMed ID: 23720982
[TBL] [Abstract][Full Text] [Related]
56. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.
Peng ZW; Lin XJ; Zhang YJ; Liang HH; Guo RP; Shi M; Chen MS
Radiology; 2012 Mar; 262(3):1022-33. PubMed ID: 22357902
[TBL] [Abstract][Full Text] [Related]
57. Ultrasound-guided percutaneous microwave ablation treatment of initial recurrent hepatocellular carcinoma after hepatic resection: long-term outcomes.
Zhang TT; Luo HC; Cui X; Zhang W; Zhang LY; Chen XP; Li KY
Ultrasound Med Biol; 2015 Sep; 41(9):2391-9. PubMed ID: 26074453
[TBL] [Abstract][Full Text] [Related]
58. Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysis.
Fukuda H; Numata K; Moriya S; Shimoyama Y; Ishii T; Nozaki A; Kondo M; Morimoto M; Maeda S; Sakamaki K; Morita S; Tanaka K
Radiology; 2014 Aug; 272(2):598-604. PubMed ID: 24689883
[TBL] [Abstract][Full Text] [Related]
59. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
[TBL] [Abstract][Full Text] [Related]
60. Clinical outcome of medium-sized hepatocellular carcinoma treated with microwave ablation.
Sun AX; Cheng ZL; Wu PP; Sheng YH; Qu XJ; Lu W; Zhao CG; Qian GJ
World J Gastroenterol; 2015 Mar; 21(10):2997-3004. PubMed ID: 25780298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
